Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

BioXcel Therapeutics, Inc.

BTAI · OTC · CIK 0001720893 · Healthcare

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

16 Form 4 transaction lines observed in the same window
4 sales · 12 option, withholding, award, gift or other lines

Last qualifying purchaseNo qualifying purchase is present in the local Form 4 history.

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Rodriguez JavierSee Remarks
○○▼○
Steinhart Richard IChief Financial Officer
○○▼○
Yocca FrankChief Scientific Officer
○○▼○
Mehta VimalCEO and President
○○▼○
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot.—

Recent Form 4 activity

0Purchases
4Sales
29Other Form 4 lines
21SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING4 sale line(s) · context only
OTHER12 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

The FINRA report lists no short interest for this ticker.

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

No qualifying code P equity purchase is present in the local Form 4 history.

Form 4 evidence

33 transaction lines in the latest 365-day window; 283 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-15Yocca FrankOption exercise / conversion (M)Common Stock35USD —USD —SEC filing ↗
2026-06-15Steinhart Richard IOption exercise / conversion (M)Common Stock35USD —USD —SEC filing ↗
2026-06-15Rodriguez JavierOption exercise / conversion (M)Common Stock35USD —USD —SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-15Yocca FrankOption exercise / conversion (M)Common Stock35USD —USD —SEC filing ↗
2026-06-15Steinhart Richard IOption exercise / conversion (M)Common Stock35USD —USD —SEC filing ↗
2026-06-15Rodriguez JavierOption exercise / conversion (M)Common Stock35USD —USD —SEC filing ↗
2026-06-15Mehta VimalOption exercise / conversion (M)Common Stock219USD —USD —SEC filing ↗
2026-05-20Yocca FrankSale (S)Common Stock6,845USD 1.09USD 7,461SEC filing ↗
2026-05-20Steinhart Richard ISale (S)Common Stock6,845USD 1.09USD 7,461SEC filing ↗
2026-05-20Rodriguez JavierSale (S)Common Stock6,560USD 1.08USD 7,085SEC filing ↗
2026-05-20Mehta VimalSale (S)Common Stock19,419USD 1.09USD 21,167SEC filing ↗
2026-05-04Yocca FrankOption exercise / conversion (M)Common Stock17,500USD —USD —SEC filing ↗
2026-05-04Steinhart Richard IOption exercise / conversion (M)Common Stock17,500USD —USD —SEC filing ↗
2026-05-04Rodriguez JavierOption exercise / conversion (M)Common Stock17,500USD —USD —SEC filing ↗
2026-05-04Mehta VimalOption exercise / conversion (M)Common Stock49,758USD —USD —SEC filing ↗
2026-05-01Yocca FrankOption exercise / conversion (M)Common Stock9,000USD —USD —SEC filing ↗
2026-05-01Steinhart Richard IOption exercise / conversion (M)Common Stock9,000USD —USD —SEC filing ↗
2026-05-01Rodriguez JavierOption exercise / conversion (M)Common Stock9,000USD —USD —SEC filing ↗
2026-05-01Mehta VimalOption exercise / conversion (M)Common Stock18,000USD —USD —SEC filing ↗
2026-03-15Yocca FrankOption exercise / conversion (M)Common Stock35USD —USD —SEC filing ↗
2026-03-15Steinhart Richard IOption exercise / conversion (M)Common Stock35USD —USD —SEC filing ↗
2026-03-15Rodriguez JavierOption exercise / conversion (M)Common Stock35USD —USD —SEC filing ↗
2026-03-15Mehta VimalOption exercise / conversion (M)Common Stock219USD —USD —SEC filing ↗
2026-03-14Yocca FrankOption exercise / conversion (M)Common Stock33USD —USD —SEC filing ↗
2026-03-14Steinhart Richard IOption exercise / conversion (M)Common Stock33USD —USD —SEC filing ↗
2026-03-14Rodriguez JavierOption exercise / conversion (M)Common Stock33USD —USD —SEC filing ↗
2026-03-14Mehta VimalOption exercise / conversion (M)Common Stock164USD —USD —SEC filing ↗
2025-12-15Yocca FrankOption exercise / conversion (M)Common Stock35USD —USD —SEC filing ↗
2025-12-15Steinhart Richard IOption exercise / conversion (M)Common Stock35USD —USD —SEC filing ↗
2025-12-15Rodriguez JavierOption exercise / conversion (M)Common Stock35USD —USD —SEC filing ↗
2025-12-15Mehta VimalOption exercise / conversion (M)Common Stock219USD —USD —SEC filing ↗
2025-12-14Yocca FrankOption exercise / conversion (M)Common Stock33USD —USD —SEC filing ↗
2025-12-14Steinhart Richard IOption exercise / conversion (M)Common Stock33USD —USD —SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerBTAI
CIK0001720893
SectorHealthcare
Industry— Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeOTC

Data coverage

Local Form 4 history283 transaction lines from 2020-02-14 to 2026-06-15
0 P purchase lines · 106 S sale lines · 177 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.